6 nominees · 3 ballot items.
Election of Directors; Approval of the Eagle Financial Services, Inc. 2026 Employee Stock Purchase Plan; Ratification of the appointment of Yount, Hyde & Barbour, P.C. as independent registered public accounting firm.
Elect four Class II directors for three-year terms (Brandon C. Lorey, Douglas C. Rinker, John D. Stokely, and Brian T. Strosser) and two Class I directors for two-year terms (Susan D. Davies and Karthik Shyamsunder).
Approve a new 2026 Employee Stock Purchase Plan reserving 160,000 shares for eligible employees to purchase shares through payroll deductions at a discount, intended to qualify under Section 423 of the Code.
The proposal asks shareholders to approve the Eagle Financial Services, Inc. 2026 Employee Stock Purchase Plan, which would reserve 160,000 shares for issuance to eligible employees through payroll deductions and discounted purchase (85% of market) across quarterly or up-to-12-month offering periods. Management seeks shareholder approval to ensure the Plan qualifies under Code Section 423 and to provide incentives for attraction and retention of employees and alignment of employee/shareholder interests. The ESPP includes governance provisions—administration by the Compensation Committee, eligibility rules, maximum per-employee purchase limits (2,000 shares per offering and $25,000 fair market value per calendar year), holding period discretion, and standard amendment/termination mechanics. Approving the plan will permit issuance of new or treasury/open-market shares and requires SEC registration if adopted. The Board unanimously recommends a FOR vote, arguing the plan supports retention/attraction and aligns employee incentives with shareholder interests; opposition risks are limited but include potential dilution (160,000 shares) and administrative costs. The plan is routine within corporate compensation practices; its tax-qualified design (Section 423) offers favorable tax treatment for participants, which management highlights as a competitive benefit.
Ratify appointment of Yount, Hyde & Barbour, P.C. as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Fourthstone LLC | 9.8% | 532,199 | $19M |
| 2 | WELLINGTON MANAGEMENT GROUP LLP | 5.2% | 280,400 | $10M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 243,742 | $9M |
| 4 | BlackRock, Inc. | 2.5% | 137,630 | $5M |
| 5 | GRAHAM CAPITAL WEALTH MANAGEMENT, LLC | 2.5% | 137,035 | $5M |
| 6 | BlackRock, Inc. | 2.2% | 116,650 | $4M |
| 7 | ALLIANCEBERNSTEIN L.P. | 1.9% | 103,716 | $4M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 86,926 | $3M |
| 9 | STATE STREET CORP | 1.6% | 84,607 | $3M |
| 10 | BANC FUNDS CO LLC | 1.2% | 65,000 | $2M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.